Keyphrases
Cardial
16%
Cost-effectiveness
16%
Cyclosporine
100%
Diagnostic Approach
16%
Disease-specific Instrument
16%
Disease-specific Quality of Life
50%
Disease-specific Questionnaire
16%
End-stage Renal Disease
66%
Enhanced Growth
16%
General Health
16%
Global Quality of Life
50%
Global Severity Index
16%
Graft Function
16%
Immunosuppression
16%
Immunosuppressive Agents
16%
Immunosuppressive Regimens
33%
Inclusion Criteria
16%
Kidney Transplant Recipients
100%
Life Effectiveness
16%
Matching Process
16%
Microemulsion
100%
Nephron
16%
Physical Capacity
16%
Physical Component Summary
16%
Physical Functioning
16%
Psychodiagnostics
16%
Quality of Life
100%
Quality of Life Assessment
33%
Quality of Life Improvement
16%
Quality of Life Study
16%
Quality of Survival
16%
Renal Disease
16%
Sensitive Diseases
16%
SF-36 Health Survey
16%
Short Form 36 (SF-36)
33%
Tacrolimus
100%
Timing Analysis
16%
Nursing and Health Professions
Analysis of Variance
10%
Ciclosporin
100%
Cost Effectiveness Analysis
10%
Diagnosis
10%
Diseases
50%
End Stage Renal Disease
40%
Health Survey
10%
Immunosuppressive Agent
30%
Immunosuppressive Treatment
10%
Microemulsions
100%
Quality of Life
100%
Quality of Life Measure
20%
Quality of Life Study
10%
Short Form 36
30%
Tacrolimus
100%
Time Factor
10%
Pharmacology, Toxicology and Pharmaceutical Science
Ciclosporin
100%
Diseases
83%
End Stage Renal Disease
66%
Health Survey
16%
Immunosuppressive Agent
50%
Microemulsions
100%
Tacrolimus
100%
Immunology and Microbiology
Ciclosporin
100%
Immunosuppression
16%
Immunosuppressive Drug
50%
Microemulsions
100%
Nephron
16%
Physical Capacity
16%
Tacrolimus
100%
Time Factor
16%
Biochemistry, Genetics and Molecular Biology
Ciclosporin
100%
Health Survey
50%
Microemulsions
100%
Physical Capacity
50%
Time Factor
50%
Psychology
Analysis of Variance
10%
Quality of Life
100%
Quality of Life Measure
20%
Quality of Life Study
10%